Apogenix GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Heidelberg Germany (2005)

Organization Overview

First Clinical Trial
2009
NCT01071837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Apogenix AG